ACTRN12615001029583已完成3 期
The use of exenatide, a GLP-1 agonist, in young people with cystic fibrosis related diabetes and impaired glucose tolerance in the management of post prandial glycaemia, gastric emptying and incretins.
Jennifer Couper0 个研究点目标入组 10 人开始时间: 2015年10月1日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 10 Years 至 25 Years（—）
- 性别
- All
入选标准
- •Male or Female patients aged 10-25 years with cystic fibrosis with exocrine pancreatic insufficiency taking pancreatic enzymes.
- •Cystic Fibrosis Related Diabetes (CFRD) (2 hour glucose on routine OGTT >11.1 mmol/L),
- •OR CFRD without fasting hyperglycaemia,
- •OR Cystic Fibrosis with Impaired Glucose Tolerance (CF with IGT) (2 hour glucose >7.8mmol/L<11.1mmol/L)
排除标准
- •Severe pulmonary disease (FEV1 <30% predicted)
- •Significant liver disease (Child-Pugh score >6)
- •Requirement for medications that could affect gastrointestinal motility (eg. erythromycin, SSRI)
- •Severe renal impairment
- •Previous stomach or small bowel surgery
- •Pregnancy or lactation
研究者
相似试验
招募中
不适用
Clinical study of GLP-1 receptor agonist (Exenatide) for type 2 diabetes patients with diabetic nephropathyJPRN-UMIN000037106Kagawa University30
进行中（未招募）
1 期
To investigate whether treatment with the GLP-1 receptor agonist exenatide improves the perception of hypoglycaemia in people with type 1 diabetes with impaired awareness of hypoglycaemiaType 1 diabetesEUCTR2016-000790-21-NLRadboudumc15
已完成
2 期
Effect of the GLP-1 receptor agonist exenatide on impaired awareness of hypoglycemia in type 1 diabetesDiabetesNL-OMON45806Radboud Universitair Medisch Centrum13
已完成
1 期
Exenatide for Treating Cocaine Use DisorderCocaine Use DisorderNCT04941521The University of Texas Health Science Center, Houston3
已完成
不适用
The Effect of GLP-1 Receptor Activation on Central Reward and Satiety in Obesity and DiabetesDiabetes MellitusObesityDiabetes Mellitus, Type 2NCT01281228Amsterdam UMC, location VUmc48